Solely Owned Sample Clauses

Solely Owned. The party solely owning any invention under Section 6.1 above shall have the sole right and responsibility (but not the obligation), at its expense, to file, prosecute and maintain all patent applications and patents thereon, and to conduct any interferences, oppositions, or reexaminations thereon, and to request any reissues or patent term extensions thereof.
Sample 1Sample 2Sample 3See All (7)
AutoNDA by SimpleDocs
Solely Owned. (a) The Party solely owning any invention or intellectual property under this Article 6 shall have the sole right and responsibility (but not the obligation), at its expense, to file, prosecute and maintain all patent applications and patents thereon, and to conduct any interferences, oppositions, or reexaminations with respect thereto, and to request any reissues or patent term extensions thereof, subject to subsections (b) and (c) below.
Sample 1
Solely Owned. Genentech may, at its sole discretion and expense, prosecute, maintain and enforce Patents covering the Genentech Project Know How (the “Genentech Project Patents”) (Genentech Project Patents and Genentech Project Know-How collectively “Genentech Project IP Rights”). SurModics may, at its sole discretion and expense, prosecute, maintain and enforce Patents covering the SurModics Project Know-How (the “SurModics Project Patents”) (SurModics Project Patents and SurModics Project Know-How collectively “SurModics Project IP Rights”). Notwithstanding the foregoing, SurModics agrees CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. to Prosecute and Maintain in the Territory, as appropriate and upon appropriate consultation with Genentech, SurModics Patents that cover Licensed Products or their use. With respect to any such SurModics’ Patents, SurModics shall keep Genentech advised of the status of any actual and prospective patent filings and, upon Genentech’s request, shall provide advance copies of any papers related to the filing, prosecution and maintenance of such patent filings. SurModics shall promptly give notice to Genentech of the grant, lapse, revocation, surrender, invalidation or abandonment of any SurModics Patents licensed to Genentech for which SurModics is responsible for the Prosecution and Maintenance. For clarity, SurModics shall have the sole right, at its sole expense, to Prosecute and Maintain the SurModics Patents to the extent such Patents do not cover the Licensed Products or the Injection Vehicles (or uses thereof).
Sample 1

Related to Solely Owned

  • Wholly-Owned Subsidiaries Nothing herein shall be construed as preventing the amalgamation or merger of any wholly-owned direct or indirect subsidiary of Parent with or into Parent or the winding-up, liquidation or dissolution of any wholly-owned subsidiary of Parent provided that all of the assets of such subsidiary are transferred to Parent or another wholly-owned direct or indirect subsidiary of Parent and any such transactions are expressly permitted by this Article 10.

  • Voting Stock Stock or similar interests, of any class or classes (however designated), the holders of which are at the time entitled, as such holders, to vote for the election of a majority of the directors (or persons performing similar functions) of the corporation, association, trust or other business entity involved, whether or not the right so to vote exists by reason of the happening of a contingency.

  • Voting Rights; Dividends; Etc (a) So long as no Event of Default shall have occurred and be continuing:

  • Ownership of Capital Stock The Shareholder is the beneficial owner of record and beneficially of all of the shares of capital stock of the Company, all of which shares are free and clear of all rights, claims, liens and encumbrances, and have not been sold, pledged, assigned or otherwise transferred except pursuant to this Agreement.

  • Voting Rights; Dividends (a) Unless and until an Event of Default shall have occurred and be continuing;

  • Capital Stock of Sub Each issued and outstanding share of capital stock of Sub shall be converted into and become one validly issued, fully paid and nonassessable share of common stock, par value $0.01 per share, of the Surviving Corporation.

  • Wholly Owned Subsidiary As to the Borrower, any Subsidiary of Borrower that is directly or indirectly owned 100% by the Borrower.

  • Capital Stock and Ownership The Capital Stock of each of Holdings and its Subsidiaries has been duly authorized and validly issued and is fully paid and non-assessable. Except as set forth on Schedule 4.2, as of the date hereof, there is no existing option, warrant, call, right, commitment or other agreement to which Holdings or any of its Subsidiaries is a party requiring, and there is no membership interest or other Capital Stock of Holdings or any of its Subsidiaries outstanding which upon conversion or exchange would require, the issuance by Holdings or any of its Subsidiaries of any additional membership interests or other Capital Stock of Holdings or any of its Subsidiaries or other Securities convertible into, exchangeable for or evidencing the right to subscribe for or purchase, a membership interest or other Capital Stock of Holdings or any of its Subsidiaries. Schedule 4.2 correctly sets forth the ownership interest of Holdings and each of its Subsidiaries in their respective Subsidiaries as of the Closing Date.

  • Capital Stock of Subsidiaries All of the outstanding capital stock of, or other equity or voting interest in, each Subsidiary of the Company (i) has been duly authorized, validly issued and is fully paid and nonassessable; and (ii) except for director’s qualifying or similar shares, is owned, directly or indirectly, by the Company, free and clear of all liens (other than Permitted Liens) and any other restriction (including any restriction on the right to vote, sell or otherwise dispose of such capital stock or other equity or voting interest) that would prevent such Subsidiary from conducting its business as of the Effective Time in substantially the same manner that such business is conducted on the date of this Agreement.

  • Equity Securities The Collateral Manager may direct the Trustee to sell any Equity Security at any time and shall use its commercially reasonable efforts to effect the sale of any Equity Security, regardless of price (provided that any sale to ORCC or its Affiliates must be on arm’s length terms), subject to any applicable transfer restrictions:

Time is Money Join Law Insider Premium to draft better contracts faster.